Evidence map›Paper›PMID 39445831›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025

A Mail-Based HPV Self-Collection Program to Increase Cervical Cancer Screening in Appalachia: Results of a Group Randomized Trial.

Paul L Reiter, Abigail B Shoben, Sarah Cooper, Amie M Ashcraft, Emma McKim Mitchell, Mark Dignan, Mark Cromo, Jean Walunis, Deborah Flinner, Dannell Boatman and 7 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Paul L ReiterCollege of Public Health, The Ohio State University, Columbus, Ohio.ORCID 0000-0001-8252-2600
Abigail B ShobenCollege of Public Health, The Ohio State University, Columbus, Ohio.ORCID 0000-0001-9347-4755
Sarah CooperCollege of Public Health, The Ohio State University, Columbus, Ohio.ORCID 0009-0003-8897-1177
Amie M AshcraftSchool of Medicine, West Virginia University, Morgantown, West Virginia.ORCID 0000-0002-7466-7612
Emma McKim MitchellSchool of Nursing, University of Virgnia, Charlottesville, Virginia.ORCID 0000-0002-3996-518X
Mark DignanCollege of Medicine, University of Kentucky, Lexington, Kentucky.ORCID 0000-0002-2657-6775
Mark CromoCollege of Medicine, University of Kentucky, Lexington, Kentucky.ORCID 0000-0002-5699-3844
Jean WalunisComprehensive Cancer Center, The Ohio State University, Columbus, Ohio.ORCID 0009-0003-3063-7125
Deborah FlinnerComprehensive Cancer Center, The Ohio State University, Columbus, Ohio.ORCID 0009-0009-5046-6590
Dannell BoatmanSchool of Medicine, West Virginia University, Morgantown, West Virginia.ORCID 0000-0003-0219-0322
Lindsay HauserCancer Center, University of Virginia, Charlottesville, Virginia.ORCID 0000-0002-5008-0243
Mack T RuffinFamily and Community Medicine, Penn State Health, Hershey, Pennsylvania.ORCID 0000-0001-8336-478X
Jerome L BelinsonPreventive Oncology International, Inc., Shaker Heights, Ohio.ORCID 0000-0003-1399-1053
Roger T AndersonDepartment of Public Health Sciences, University of Virginia, Charlottesville, Virginia.ORCID 0000-0001-8112-4117
Stephenie Kennedy-ReaSchool of Medicine, West Virginia University, Morgantown, West Virginia.ORCID 0000-0001-7230-1484
Electra D PaskettCollege of Public Health, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-8247-8299
Mira L KatzCollege of Public Health, The Ohio State University, Columbus, Ohio.ORCID 0000-0001-9791-7592

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
Project 3: A Multilevel HPV Self-Testing Intervention to Increase Cervical Cancer Screening among Women in AppalachiaP01CA229143 · NCI · OHIO STATE UNIVERSITY · PI PASKETT, ELECTRA D. · 2019 to 2023
$11.5M
National Institutes of Health (NIH) P01CA229143National Institutes of Health (NIH) P30CA016058NCATS NIH HHS UL1 TR001070NCI NIH HHS P01 CA229143NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

backgroundDespite the promise of mail-based human papillomavirus (HPV) self-collection programs for increasing cervical cancer screening, few have been evaluated in the United States. We report the results of a mail-based HPV self-collection program for underscreened women living in Appalachia.

methodsWe conducted a group randomized trial from 2021 to 2022 in the Appalachian regions of Kentucky, Ohio, Virginia, and West Virgnia. Participants were women of ages 30 to 64 years who were underscreened for cervical cancer and from a participating health system. Participants in the intervention group (n = 464) were mailed an HPV self-collection kit followed by telephone-based patient navigation (if needed), and participants in the usual care group (n = 338) were mailed a reminder letter to get a clinic-based cervical cancer screening test. Generalized linear mixed models compared cervical cancer screening between the study groups.

resultsOverall, 14.9% of participants in the intervention group and 5.0% of participants in the usual care group were screened for cervical cancer. The mail-based HPV self-collection intervention increased cervical cancer screening compared with the usual care group (OR, 3.30; 95% confidence interval, 1.90-5.72; P = 0.005). One or more high-risk HPV types were detected in 10.5% of the returned HPV self-collection kits. Among the participants in the intervention group whom patient navigators attempted to contact, 44.2% were successfully reached.

conclusionsHPV self-collection increased cervical cancer screening, and future efforts are needed to determine how to optimize such programs, including the delivery of patient navigation services. IMPACT: Mail-based HPV self-collection programs are a viable strategy for increasing cervical cancer screening among underscreened women living in Appalachia.

Indexed as

Early Detection of CancerPapillomavirus InfectionsPostal ServiceUterine Cervical NeoplasmsAdultAppalachian RegionFemaleHumansMiddle AgedPapillomaviridaeSpecimen Handling

Identifiers

PMID39445831
PMCPMC11717618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.